海洋生物技術市場規模、佔有率和成長分析（按類型、技術、應用、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，全球海洋生物技術市場規模將達到 69.5 億美元，到 2025 年將成長至 74.3 億美元，到 2033 年將成長至 126.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 6.9%。

全球海洋生物技術市場正經歷顯著成長，它利用海洋豐富的資源來推動醫療保健、農業和能源領域的創新產品。該領域利用海洋生物的特異性特性，開發包括治療藥物和生質燃料在內的生物技術產品。市場潛力巨大，這得益於對永續和環保解決方案的日益成長的需求，以及慢性病患病率的上升。然而，高昂的研發成本、有限的海洋資源取得以及監管障礙等挑戰依然存在。但生物技術的進步和行業相關人員之間日益密切的合作預計將推動市場成長。值得關注的趨勢包括海洋酵素和海洋生醫材料在各行業的應用不斷擴展，凸顯了該領域巨大的創新和發展機會。

推動全球海洋生物技術市場發展的因素

人們對環境議題的日益關注以及對永續性的追求，顯著提升了各行各業對環保產品的需求。在此背景下，海洋生物技術正成為永續解決方案的重要來源，為工業應用提供創新替代方案，例如海洋來源的酵素、生質燃料和生質塑膠。例如，一些公司正在利用藻類生產可生物分解的生質塑膠材料，作為傳統塑膠的永續替代品。這一趨勢反映了一種更廣泛的趨勢，即以符合生態責任的方式利用海洋資源，並致力於建立更永續的未來。

抑制全球海洋生物技術市場

全球海洋生物技術市場面臨諸多限制因素，主要源自於海洋衍生產品研發的高成本。這個複雜過程包括識別和培養多種海洋生物，以及提取和純化其中有價值的生物活性化合物。光是培養和萃取一種海洋衍生化合物的成本就十分巨大，往往高達數百萬美元。這些高昂的成本對海洋生物技術產品的成長和商業化都構成了挑戰，阻礙了該產業充分利用海洋環境中豐富的資源。

全球海洋生物技術市場趨勢

海洋生醫材料的應用是全球海洋生物技術市場的一大趨勢，尤其是在醫療保健、組織工程和再生醫學等領域。海洋膠原蛋白等資源具有優於傳統哺乳動物來源材料的功效和生物相容性，研究人員正利用這些資源探索其在創傷治療和組織再生方面的創新應用。鑑於海洋生物活性化合物在醫療保健解決方案中具有永續和環境友善替代方案的巨大潛力，相關投資和研究正在蓬勃發展。隨著技術的進步，海洋生醫材料材料的整合應用有望進一步推進，從而改善治療效果並促進跨學科合作。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球海洋生物技術市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 生物活性物質
• 生物材料

全球海洋生物技術市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 微生物的分離與培養
• 與文化無關的技術

全球海洋生物技術市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 水產養殖和食品
• 環境/人體健康
• 藥物發現

全球海洋生物技術市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 食品工業
• 製藥和生物技術產業
• 化工
• 化妝品產業

全球海洋生物技術市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• BASF（Germany）
• Key Developments
• Cyanotech Corp.（USA）
• Kerry Group（Ireland）
• Corbion（Netherlands）
• FMC Corp.（USA）
• Marine Biotech（USA）
• Royal DSM（Netherlands）
• TransGen Biotech Co., Ltd.（China）
• Olmix Group（France）
• Ittinsect（Italy）
• BRAIN Biotech AG（Germany）
• Biotech Marine（France）
• Marinova Pty Ltd（Australia）
• Pharma Mar, SA（Spain）
• GlycoMar Ltd.（UK）
• Aker BioMarine ASA（Norway）
• oceanBASIS GmbH（Germany）
• Primex Iceland（Iceland）
• New England Biolabs（NEB）（USA）

結論與建議

Global Marine Biotechnology Market size was valued at USD 6.95 Billion in 2024 and is poised to grow from USD 7.43 Billion in 2025 to USD 12.67 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global marine biotechnology market is experiencing significant growth, leveraging the abundant resources of the oceans to innovate products across medicine, agriculture, and energy. This sector capitalizes on the unique properties of marine organisms to produce biotechnological advancements, including therapeutics and biofuels. A surge in demand for sustainable and eco-friendly solutions, alongside the rise in chronic disease prevalence, underscores the market potential. Challenges such as high R&D costs, restricted access to marine resources, and regulatory barriers persist. However, advancements in biotechnology and an increase in collaborations among industry stakeholders are poised to propel market growth. Notable trends include the rising application of marine-derived enzymes and marine biomaterials in diverse industries, highlighting vast opportunities for innovation and development in this space.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Marine Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Marine Biotechnology Market Segments Analysis

Global Marine Biotechnology Market is segmented by Type, Technology, Application, End-user and region. Based on Type, the market is segmented into Bio Active Substance and Bio Materials. Based on Technology, the market is segmented into Isolation and Cultivation of Microorganisms and Culture-Independent Techniques. Based on Application, the market is segmented into Aquaculture and Food Products, Environment & Human Health and Drug Discovery. Based on End-user, the market is segmented into Food Industry, Pharmaceutical and Biotechnology Industry, Chemical Industry and Cosmetic Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Marine Biotechnology Market

The heightened awareness surrounding environmental issues and the push for sustainability have significantly boosted the demand for eco-friendly products across numerous sectors. In this context, marine biotechnology emerges as a vital source of sustainable solutions, providing innovative alternatives like marine-derived enzymes for industrial uses, as well as biofuels and bioplastics. For example, some companies are harnessing algae to create biodegradable bioplastic materials, which serve as sustainable substitutes for conventional plastics. This trend reflects a broader movement toward utilizing marine resources in a way that aligns with ecological responsibility and contributes to a more sustainable future.

Restraints in the Global Marine Biotechnology Market

The Global Marine Biotechnology market faces significant constraints primarily due to the high costs associated with the research and development of marine-derived products. This intricate process encompasses the identification and cultivation of diverse marine organisms, alongside the extraction and purification of valuable bioactive compounds. The financial burden of cultivating and extracting even a single marine-derived compound can reach substantial amounts, often totaling several hundred thousand dollars. Such steep expenses pose challenges to both the growth and commercialization of marine biotechnology products, hindering the industry's potential to fully capitalize on the wealth of resources available in marine environments.

Market Trends of the Global Marine Biotechnology Market

The Global Marine Biotechnology market is witnessing a significant trend towards the utilization of marine-derived biomaterials, particularly in areas such as medicine, tissue engineering, and regenerative therapies. Leveraging the unique properties of resources like marine collagen, which surpasses traditional mammalian alternatives in efficacy and biocompatibility, researchers are exploring innovative applications in wound healing and tissue regeneration. This focus on bioactive compounds derived from marine sources is driving investment and research, as industries recognize the potential for sustainable, environmentally friendly alternatives in healthcare solutions. As technologies advance, the integration of marine biomaterials is expected to evolve, enhancing therapeutic outcomes and fostering interdisciplinary collaboration.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Marine Biotechnology Market Size by Type & CAGR (2026-2033)

• Market Overview
• Bio Active Substance
• Bio Materials

Global Marine Biotechnology Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Isolation and Cultivation of Microorganisms
• Culture-Independent Techniques

Global Marine Biotechnology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Aquaculture and Food Products
• Environment & Human Health
• Drug Discovery

Global Marine Biotechnology Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Food Industry
• Pharmaceutical and Biotechnology Industry
• Chemical Industry
• Cosmetic Industry

Global Marine Biotechnology Market Size & CAGR (2026-2033)

• North America (Type, Technology, Application, End-user)
  • US
  • Canada
• Europe (Type, Technology, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Cyanotech Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corbion (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMC Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marine Biotech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransGen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olmix Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ittinsect (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BRAIN Biotech AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotech Marine (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marinova Pty Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharma Mar, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoMar Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aker BioMarine ASA (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• oceanBASIS GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Primex Iceland (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (NEB) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations